Related Experiment Video
Updated: Aug 17, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Dilated cardiomyopathy mutations in three thin filament regulatory proteins result in a common functional phenotype
Mahmooda Mirza1, Steven Marston, Ruth Willott
1National Heart and Lung Institute, Imperial College London, London SW3 6LY, United Kingdom.
Insights
Inherited dilated cardiomyopathy (DCM) mutations in cardiac muscle proteins reduce heart contractility. This contrasts with hypertrophic cardiomyopathy mutations, suggesting distinct molecular mechanisms drive these heart conditions.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Muscle Physiology
Background:
- Dilated cardiomyopathy (DCM) is a primary cause of heart failure, often stemming from inherited genetic mutations.
- Mutations in cardiac troponin T, troponin C, and alpha-tropomyosin genes are linked to inherited DCM, but can also cause hypertrophic cardiomyopathy with different mutations.
- Conflicting findings in prior studies necessitate a comprehensive analysis of DCM-associated mutations.
Purpose of the Study:
- To elucidate how specific genetic mutations lead to dilated cardiomyopathy.
- To investigate the impact of known DCM-causing mutations on cardiac contractile function.
- To compare the functional effects of DCM mutations with those causing hypertrophic cardiomyopathy.
Main Methods:
- Reconstitution of cardiac thin filaments with wild-type and mutant proteins (troponin T, troponin C, alpha-tropomyosin) at a 1:1 ratio.
- In vitro assays including ATPase activity and motility assays to assess Ca(2+) sensitivity and activation.
- Inclusion of skinned cardiac trabeculae experiments with specific troponin T mutants to evaluate force generation.
Main Results:
- All thin filaments with DCM mutations exhibited reduced Ca(2+) sensitivity in ATPase and motility assays.
- Most mutants showed decreased maximum Ca(2+) activation, with one exception (alpha-tropomyosin).
- Incorporation of two troponin T mutants into cardiac trabeculae reduced Ca(2+) sensitivity of force generation.
Conclusions:
- Diverse thin filament DCM mutations consistently impair myofibrillar function, leading to decreased contractility.
- This depressive effect on contractility is mechanistically opposite to that observed in hypertrophic cardiomyopathy-causing thin filament mutations.
- Reduced cardiac contractility due to these mutations may initiate pathological pathways culminating in the clinical presentation of DCM.
Abstract:
Dilated cardiomyopathy (DCM), characterized by cardiac dilatation and contractile dysfunction, is a major cause of heart failure. Inherited DCM can result from mutations in the genes encoding cardiac troponin T, troponin C, and alpha-tropomyosin; different mutations in the same genes cause hypertrophic cardiomyopathy. To understand how certain mutations lead specifically to DCM, we have investigated their effect on contractile function by comparing wild-type and mutant recombinant proteins. Because initial studies on two troponin T mutations have generated conflicting findings, we analyzed all eight published DCM mutations in troponin T, troponin C, and alpha-tropomyosin in a range of in vitro assays. Thin filaments, reconstituted with a 1:1 ratio of mutant/wild-type proteins (the likely in vivo ratio), all showed reduced Ca(2+) sensitivity of activation in ATPase and motility assays, and except for one alpha-tropomyosin mutant showed lower maximum Ca(2+) activation. Incorporation of either of two troponin T mutants in skinned cardiac trabeculae also decreased Ca(2+) sensitivity of force generation. Structure/function considerations imply that the diverse thin filament DCM mutations affect different aspects of regulatory function yet change contractility in a consistent manner. The DCM mutations depress myofibrillar function, an effect fundamentally opposite to that of hypertrophic cardiomyopathy-causing thin filament mutations, suggesting that decreased contractility may trigger pathways that ultimately lead to the clinical phenotype.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
The Sarcomere
Each myosin...
Heart Failure II: Pathophysiology
Actin Polymerization and Cell Motility
Actin cytoskeleton dynamics can produce pushing, pulling, and resistance forces that help the cell to migrate.

